Advances in the pathology of COPD

Histopathology

Volumn 49, Issue 1, 2006, Pages 1-9

  Wright, J L ^a,b   Churg, A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Airway; Artery; Cigarette smoke; Emphysema

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; LUNG EMPHYSEMA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TISSUE FIXATION;

AIRWAY RESISTANCE; ANIMALS; DIAGNOSIS, DIFFERENTIAL; DISEASE MODELS, ANIMAL; HUMANS; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; VASCULAR DISEASES;

EID: 33745650657     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2006.02395.x     Document Type: Review

References (19)

1. American Thoracic Society. Chronic bronchitis, asthma and pulmonary emphysema. A statement by the Committee on Diagnostic Standards for Nontuberculosis Respiratory Diseases. Am. Rev. Respir. Dis. 1962; 85; 762-768.
2. National Heart Lung and Blood Institute, World Health Organization. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, NHLBI/WHO Workshop, 2001.
3. Thurlbeck WM, Dunnill MS, Hartung W, Heard B, Heppleston A, Ryder RC. A comparison of three methods of measuring emphysema. Hum. Pathol. 1970; 1; 215-226.
4. Nagai A, Yamawaki I, Thurlbeck WM, Takizawa T. Assessment of lung parenchymal destruction by using routine histologic tissue sections. Am. Rev. Respir. Dis. 1989; 139; 313-319.
5. Thurlbeck WM, Wright JL. Thurlbeck's chronic airflow obstruction, 2nd edn. Hamilton, BC: Decker 1999.
6. Cardoso WV, Sekhon HS, Hyde DM, Thurlbeck WM. Collagen and elastin in human pulmonary emphysema. Am. Rev. Respir. Dis. 1993; 147; 975-981.
7. Mahadeva R, Shapiro SD. Chronic obstructive pulmonary disease 3: Experimental animal models of pulmonary emphysema. Thorax 2002; 57; 914.
8. Shapiro SD, Ingenito EP. The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. Am. J. Respir. Cell Mol. Biol. 2005; 32; 367-372.
9. Tuder RM, McGrath S, Neptune E. The pathobiological mechanisms of emphysema models: what do they have in common? Pulm. Pharmacol. Ther. 2003; 16; 67-78.
10. Churg A, Wright JL. Proteases and emphysema. Curr. Opin. Pulmon. Med. 2005; 11; 153-159.
11. Wright JL, Churg A. Animal models of cigarette smoke-induced lung disease. Minerva Pneumologica 2003; 42; 85-99.
12. Hogg JC, Chu F, Utokaparch S et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350; 2645-2653.
13. Willems LNA, Kramps JA, Stijnen Sterk PJ, Weening JJ, Dijkman JH. Relation between small airways disease and parenchymal destruction in surgical lung specimens. Thorax 1990; 45; 89-94.
14. Wright JL, Lawson LM, Kennedy S, Wiggs B, Hogg JC. The detection of small airways disease. Am. Rev. Respir. Dis. 1984; 129; 989-994.
15. Wang RD, Tai H, Xie C, Wang X, Wright JL, Churg A. Cigarette smoke produces airway wall remodeling in rat tracheal explants. Am. J. Respir. Crit. Care Med. 2003; 168; 1232-1236.
16. Wang RD, Wright JL, Churg A. Transforming growth factor-beta 1 drives airway remodeling in cigarette smoke-exposed tracheal explants. Am. J. Respir. Cell Mol. Biol. 2005; 33; 387-393.
17. Hale KA, Ewing SL, Gosnell BA, Niewoehner DE. Lung disease in long-term cigarette smokers with and without chronic air-flow obstruction. Am. Rev. Respir. Dis. 1984; 130; 716-721.
18. Dinh-Xuan AT, Higenbottam TW, Clelland CA et al. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N. Engl. J. Med. 1991; 324; 1539-1547.
19. Wright JL, Tai H, Churg A. Vasoactive mediators and pulmonary hypertension after cigarette smoke exposure in the guinea pig. J. Appl. Physiol. 2006; epub.